Summit Partners
Summit Partners is a leading growth-focused alternative investment firm founded in 1984, aiming to back category-leading companies in Technology, Healthcare & Life Sciences, and Growth Products & Services.
Funder analysis
Web-researched analysis· 25 Jul 2026· v7What they fund
- Stage — Growth equity, typically minority or majority stakes in established, category-leading companies [1].
- Sector — Technology, Healthcare & Life Sciences, and Growth Products & Services [1].
- Geography — Primarily US and Europe, with examples like AVAST Software (Prague, Czech Republic) and Ogone (Belgium) [2].
- Shape — Private equity investments, including significant rounds like the $100 million investment in AVAST Software [2].
Investment thesis
Summit Partners aims to be the investment partner of choice for the very best companies and executive talent, seeking to invest in category-leading companies across Technology, Healthcare & Life Sciences, and Growth Products & Services [1]. The firm provides resources to drive profitable growth and build lasting value, leveraging decades of experience to support the growth of people and the companies they lead [1]. They take a collaborative approach to investing, whether as a minority or majority partner, understanding that category leadership is rare [1].
Credibility: Summit Partners homepage, 'Our Approach' and 'Our Portfolio' sections.
Value add
Summit Partners provides resources to drive profitable growth and build lasting value, leveraging decades of experience to support the growth of people and the companies they lead [1]. They take a collaborative approach to investing, whether as a minority or majority partner [1].
Fit verdict: Ideal for category-leading growth companies in Tech, Healthcare, and Growth Services seeking a long-term, collaborative partner with deep industry expertise and a global footprint.
Founder diligence script:
- What specific resources beyond capital will you provide to help us scale our operations in [specific market]?
- How do you typically engage with our executive team to support talent development and retention?
- Can you share examples of how your collaborative approach has helped portfolio companies navigate significant growth challenges?
- What is your typical timeline for decision-making and follow-on investments?
- How do you measure success for your growth equity investments, and what are your expectations for our exit strategy?
Portfolio focus
- Technology — Keyfactor (AI and post-quantum enterprise security), Darktrace (AI in cyber security), StackAdapt (data-driven growth), onX (digital outdoor navigation) [1].
- Healthcare & Life Sciences — VaxCare (preventative care), BluePearl (veterinary care), CluePoints (modernizing clinical trials), Healthline Media (consumer health) [1].
- Growth Products & Services — Odoo (business apps), InvoiceCloud (customer engagement), Dr. Squatch (personal care, acquired by Unilever), Global Gruppe (insurance services) [1].
Notable investments & exits
- AVAST Software — Summit Partners invested $100 million in AVAST Software in 2010 [2]. The company was later acquired by Gen Digital (formerly NortonLifeLock) in 2016 for approximately $2.8 billion [2].
- Dr. Squatch — Summit Partners backed Dr. Squatch, which was acquired by Unilever in 2021 [1].
- Ogone — Summit Partners acquired a majority stake in Ogone, a Belgium-based e-payments provider, which was later acquired by Worldline [2].
- Public Offerings — The firm has supported 175+ public offerings, indicating a track record of successful IPO exits [1].
- Strategic Sales — The firm has facilitated 250+ strategic sales or mergers, demonstrating a strong exit capability [1].
Strategic implications
Summit Partners' $44B+ AUM and 41+ years of experience provide a significant moat in sourcing and supporting category-leading growth companies. Their focus on Technology, Healthcare & Life Sciences, and Growth Products & Services aligns with high-growth, high-margin sectors. The firm's collaborative approach and focus on executive talent suggest a strong ability to add value beyond capital, which can be a key differentiator for founders. Their active deployment and significant number of exits indicate a robust pipeline and execution capability, but also suggest a competitive landscape for deal flow. The firm's global footprint, particularly in the US and Europe, allows them to support companies with international expansion strategies. Their focus on growth equity, rather than early-stage venture, positions them as a later-stage partner, which may limit their ability to capture early-stage upside but provides stability and scale.
Where they could go further
Summit Partners could deepen its engagement with the AI and post-quantum security space, given the strategic importance of these technologies and their existing portfolio companies like Keyfactor and Darktrace. The firm could expand its focus on climate tech and sustainability, a growing sector with significant investment opportunities and societal impact. Summit Partners could enhance its support for portfolio companies in navigating regulatory challenges, particularly in the Healthcare & Life Sciences sector. The firm could develop more structured programs for executive talent development and retention, leveraging its focus on backing the best executives.